Search clinical trials for: Autologous cardiac stem cells (JRM-001)

Total 780 results

University Medical Centre Ljubljana
Stanford University; Blood Transfusion Centre of Slovenia

Completed

Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

Dilated Cardiomyopathy

Slovenia
Vinmec Research Institute of Stem Cell and Gene...

Not yet recruiting

Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female

Sexual Dysfunction Female

Vietnam
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

Breast Cancer

United States
Holostem Terapie Avanzate s.r.l.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; University of Modena...

Suspended

Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure (HOLOUR)

Hypospadias

Italy
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate) (PD)

Parkinson Disease

United States
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Autologous Stem Cells in Osteoarthritis

Osteoarthritis, Knee

Mexico
Ain Shams University

Completed

Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children

Obesity, Childhood

Egypt
Wenzhou Medical University

Unknown

ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis

Liver Cirrhosis | Surgery | Portal Hypertension | Hepatic Decompensation

China
Zhi-Hong Liu, M.D.
Nanjing Medical University; Soochow University

Completed

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Amyloidosis

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Refractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
Great Ormond Street Hospital for Children NHS Foundation...
Orchard Therapeutics

Completed

Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency

Adenosine Deaminase Deficiency | Severe Combined Immunodeficiencies (SCID)

United Kingdom
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide

Healthy

Germany
Makerere University

Completed

Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.

Feasibility | Keloid | Safety | Autologus Adipose Derived Stem Cells

Uganda
Tigenix S.A.U.

Terminated

Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease (FATT)

Crohn Disease | Complex Perianal Fistula

Spain, Netherlands, Austria
Ronald Levy
National Institutes of Health (NIH)

Completed

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Lymphoma, Mantle-Cell

United States
University of Arkansas

Completed

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

Multiple Myeloma

United States
Qilu Hospital of Shandong University

Recruiting

Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

Multiple Myeloma

China
Pharmicell Co., Ltd.

Completed

REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

Alcoholic Liver Cirrhosis

Korea, Republic of
Washington University School of Medicine

Terminated

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin Lymphoma

United States
University of Colorado, Denver
Sanofi

Completed

Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation

Pulmonary Fibrosis | Cystic Fibrosis | COPD

United States
Ottawa Hospital Research Institute
Multiple Sclerosis Scientific Research Foundation

Completed

Autologous Stem Cell Transplant for Multiple Sclerosis (MS/BMT)

Multiple Sclerosis

Canada
Northwestern University
University of Sao Paulo General Hospital

Withdrawn

Hematopoietic Stem Cell Support Versus Insulin in T1D

Diabetes Mellitus, Type 1
Wuerzburg University Hospital
Celgene Corporation; Amgen; ClinAssess GmbH; medac GmbH

Completed

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Germany
VA Office of Research and Development
National Cancer Institute (NCI); Jonsson Comprehensive Cancer Center

Terminated

A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer (VTNSCLC)

Non-Small Cell Lung Cancer (NSCLC)

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell Myeloma | Secondary Amyloidosis

United States
National University of Malaysia
Cytopeutics Pte. Ltd.

Unknown

Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis

Osteoarthritis

Malaysia
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult... and other conditions

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins All Children's Hospital

Withdrawn

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Neoplasms, Nerve Tissue | Neuroblastoma
Wenzhou Medical University

Unknown

Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases. (ABMSCIFTLD)

Liver Diseases

China
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis

Osteoarthritis Knee

Bangladesh
University of Florida
Oligo Nation, Inc

Not yet recruiting

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients (ADAGiO)

Recurrent Oligodendroglioma | Progressive Oligodendroglioma

United States
Chinese University of Hong Kong

Completed

RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee): (MSC)

Osteoarthritis, Knee

Hong Kong
Mayo Clinic
National Cancer Institute (NCI)

Completed

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Comparison of Allogeneic Matched Related Haematopoietic Stem Cell Transplantation After a Reduced Intensity Conditioning Regimen With Standard of Care in Adolescents and Adults With Severe Sickle Cell Disease (DREPA-RIC)

Sickle Cell Disease
Institut Cancerologie de l'Ouest

Terminated

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse (TOMMY)

Multiple Myeloma in Relapse

France
IRCCS San Raffaele
Fondazione Telethon

Active, not recruiting

Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant (TigetT10_MPSIH)

Mucopolysaccharidosis IH

Italy
Boston Medical Center

Terminated

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Multiple Myeloma | Plasma Cell Neoplasm

United States
KLSMC Stem Cells, Inc.

Completed

Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee

Articular Cartilage Disorder of Knee | Articular Cartilage; Degeneration

United States, Malaysia
Wuerzburg University Hospital
Celgene Corporation; ClinAssess GmbH

Active, not recruiting

Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance

Previously Untreated Symptomatic Multiple Myeloma

Germany
University College, London
Amgen

Active, not recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma (Cardamon)

Multiple Myeloma

United Kingdom
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
St. Jude Children's Research Hospital
University of Miami

Completed

Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

Neuroblastoma | Central Nervous System Tumors | Wilms Tumor | Lymphomas

United States
Lymphoma Study Association

Terminated

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

CD20-Positive Large B-Cell Lymphoma

France
M.D. Anderson Cancer Center
Cytogen Corporation

Completed

Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases

Breast Cancer | Bone Metastases

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

Acute Myeloid Leukemia

United States
New Approaches to Neuroblastoma Therapy Consortium
National Cancer Institute (NCI)

Completed

N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma

Neuroblastoma

United States
Northwestern University

Terminated

Hematopoietic Stem Cell Support in Vasculitis

Vasculitis

United States

Search clinical trials for: Autologous cardiac stem cells (JRM-001)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations